Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Resident, Duke University School of Medicine 2004 - 2007
  • M.D., Medical University of South Carolina, School of Medicine 2004
• 

  Duke Appointment History

  • Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2013 - 2020
  • Medical Instructor in the Department of Medicine, Medicine, Medical Oncology, Medicine 2010 - 2013
• Recognition
• 

  In the News

  • APR 20, 2015

    The News & Observer

    Duke oncologist touts new screening for lung cancer
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Ettinger, David S., Charles R. Handorf, Mark Agulnik, Daniel W. Bowles, Justin M. Cates, Mihaela Cristea, Efrat Dotan, et al. “Occult primary, version 3.2014.” J Natl Compr Canc Netw 12, no. 7 (July 2014): 969–74. https://doi.org/10.6004/jnccn.2014.0093.
       Full Text  Link to Item
    • Stevenson, Marvaretta, Jared Christensen, Debra Shoemaker, Traci Foster, William T. Barry, Betty C. Tong, Momen Wahidi, et al. “Tumor acquisition for biomarker research in lung cancer.” Cancer Invest 32, no. 6 (July 2014): 291–98. https://doi.org/10.3109/07357907.2014.911880.
       Full Text  Link to Item
    • Stevenson, Marvaretta M., Tonia Irwin, Terry Lowry, Maleka Z. Ahmed, Thomas L. Walden, Melanie Watson, and Linda Sutton. “Development of a virtual multidisciplinary lung cancer tumor board in a community setting.” J Oncol Pract 9, no. 3 (May 2013): e77–80. https://doi.org/10.1200/JOP.2013.000882.
       Full Text  Link to Item
    • Stevenson, Marvaretta Miesha, Tonia Irwin, Terry Lowry, Maleka Zafreen Ahmed, Thomas L. Walden, and Linda Sutton. “Development of a virtual multidisciplinary lung cancer tumor board in a community setting.” Journal of Clinical Oncology 30, no. 34_suppl (December 1, 2012): 325–325. https://doi.org/10.1200/jco.2012.30.34_suppl.325.
       Full Text
    • Stevenson, Marvaretta, and Anil Potti. “A pathway-based approach to identify molecular biomarkers in cancer.” Ann Surg Oncol 19 Suppl 3 (July 2012): S620–24. https://doi.org/10.1245/s10434-011-1855-4.
       Full Text  Link to Item
    • Hsu, D. S., C. R. Acharya, B. S. Balakumaran, R. F. Riedel, M. K. Kim, M. Stevenson, S. Tuchman, et al. “Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 13 (5312-5317) DOI: 10.1073/pnas.0900827106).” Proceedings of the National Academy of Sciences of the United States of America 108, no. 35 (2011): 14705-. https://doi.org/10.1073/pnas.1111196108.
       Full Text
    • Mostertz, William, Marvaretta Stevenson, Chaitanya Acharya, Isaac Chan, Kelli Walters, Wisut Lamlertthon, William Barry, Jeffrey Crawford, Joseph Nevins, and Anil Potti. “Age- and sex-specific genomic profiles in non-small cell lung cancer.” Jama 303, no. 6 (February 10, 2010): 535–43. https://doi.org/10.1001/jama.2010.80.
       Full Text  Link to Item
    • Stevenson, Marvaretta, William Mostertz, Chaitanya Acharya, William Kim, Kelli Walters, William Barry, Kristin Higgins, et al. “Characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.” Clin Cancer Res 15, no. 24 (December 15, 2009): 7553–61. https://doi.org/10.1158/1078-0432.CCR-09-1939.
       Full Text  Link to Item
    • Rao, Arati V., Peter J. M. Valk, Klaus H. Metzeler, Chaitanya R. Acharya, Sascha A. Tuchman, Marvaretta M. Stevenson, David A. Rizzieri, et al. “Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.” J Clin Oncol 27, no. 33 (November 20, 2009): 5580–86. https://doi.org/10.1200/JCO.2009.22.2547.
       Full Text  Link to Item
    • Stevenson, M. M., W. Mostertz, C. Acharya, K. Walters, W. Barry, S. Tuchman, N. Ready, M. Onaitis, J. Crawford, and A. Potti. “Characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.” J Clin Oncol 27, no. 15_suppl (May 20, 2009): 11001.
       Link to Item
    • Hsu, David S., Chaitanya R. Acharya, Bala S. Balakumaran, Richard F. Riedel, Mickey K. Kim, Marvaretta Stevenson, Sascha Tuchman, et al. “Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.” Proc Natl Acad Sci U S A 106, no. 13 (March 31, 2009): 5312–17. https://doi.org/10.1073/pnas.0900827106.
       Full Text  Link to Item

  • Other Articles

    • Stevenson, Marvaretta, William Mostertz, Chaitanya R. Acharya, William Kim, Kelli Walters, William Barry, Kristin Higgins, et al. “Retraction: characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.” Clin Cancer Res, March 15, 2012. https://doi.org/10.1158/1078-0432.CCR-12-0337.
       Full Text  Link to Item

  • Conference Papers

    • Clarke, Jeffrey Melson, Xiaofei F. Wang, Lin Gu, Marvaretta Miesha Stevenson, Tom Stinchcombe, Sundhar Ramalingam, Scott Joseph Antonia, et al. “Interim results from the OPTIMAL trial: A phase II clinical trial of combination nivolumab, ipilimumab, and taxane in patients with untreated metastatic non-small cell lung cancer (NSCLC).” In Journal of Clinical Oncology, Vol. 38, 2020.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.